BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

ChinaBio(R) LLC Week in Review: China Leads Emerging Countries' Pharma M&A


12/17/2012 10:58:05 AM

by Richard Daverman, PhD

December 15, 2012 -- Spending on pharmaceutical M&A deals is up 67% in emerging markets this year, and China, with one-third of the activity, leads the pack; Sinopharm and China Development Bank signed a $6.4 billion agreement to help Sinopharm expand and modernize; Fosun Pharma and Dalian Wanchun Biotech will establish a JV to develop innovative oncology treatments; the Shanghai Institute of Biochemistry and Cell Biology is collaborating with MRC Technology of the UK to develop new drug targets; Jiangxi Boya Bio-Pharma will pay up to $18.5 million to purchase a 68% stake in Zhejiang Haikang Biologicals; DelMar Pharma of Vancouver talked to ChinaBio® Today about its partnership with Guangxi Wuzhou Pharma on a cancer treatment; Mauna Kea Technologies was granted SFDA approval to market its probe-based microscope, Cellvizio®, in China; and Veridex, a Johnson & Johnson company, received SFDA approval for CellSearch, an in vitro diagnostic device that tests for circulating tumor cells in the bloodstream. More details….

Stock Symbols: (SHA: 600196; HK: 2196) (SHA: 300294) (EN: MKEA) (NYSE: JNJ)



Read at ChinaBio Today

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->